Lab
Primary Diagnostics Laboratory PLLC
Primary Diagnostics Laboratory PLLC was paid $6K by Medicaid between Aug 2022 and Jul 2023, across 4 billing codes. Its largest line is K1034, Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count — 65% of everything it billed.
33Billing provider infoPRIMARY DIAGNOSTICS LABORATORY PLLC
HOLLYWOOD, FL 33020
HOLLYWOOD, FL 33020
33aNPI1942641923assigned 07/08/2013
33bProvider typeClinical Medical Laboratory
28Total paid$6K
24GClaims1,566
24DCodes billed4
24AFirst – last monthAug 2022 – Jul 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#164 of 225
Median peer was paid$74K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 266 | $411.21 | |
| 2023 | 1,300 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 65% | 1,218 | 1,163 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 24% | 169 | 107 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 30 | 29 | $649.39 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 149 | 92 | $24.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUMAS, JEAN-ROBERT (OWNER)